# LEVOTHYROXINE SODIUM

NDC: 31722-293
Generic name: levothyroxine sodium
Labeler / Manufacturer: Camber Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20230118

FDA application: ANDA215259

## Active ingredients

- LEVOTHYROXINE SODIUM: .175 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"31722-293"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=31722-293
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1ba1c7d-371a-4aa8-bee8-dd29b5e7da7e